January 25, 2018 / 2:12 PM / 6 months ago

BRIEF-Novan Announces First Patient Dosed In Phase 2 Molluscum Contagiosum Trial With SB206

Jan 25 (Reuters) - Novan Inc:

* NOVAN ANNOUNCES FIRST PATIENT DOSED IN PHASE 2 MOLLUSCUM CONTAGIOSUM TRIAL WITH SB206

* NOVAN INC - TOP LINE RESULTS ARE TARGETED FOR Q4 OF 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below